Global Esoteric Assays Market Size, Share, Opportunities And Trends By Technology (Mass Spectrometry, Flow Cytometry, Real-Time PCR, Enzyme-linked Immunosorbent Assay, Radioimmunoassay, Chemiluminescence, Others), By Application (Oncology, Neurology, Infectious Diseases, Genetic Diseases, Toxicology, Others), By End Users (Hospitals Laboratories, Independent & Reference Laboratorie), And By Geography - Forecasts From 2019 To 2024

  • Published : Mar 2020
  • Report Code : KSI061612088
  • Pages : 97

The global Esoteric Assays market is expected to reach $XX billion by 2023 from $XX billion in 2017 growing at a CAGR of XX%. Esoteric testing is the analysis of unique, rare molecules that are not performed in routine clinical laboratories and requires a skilled personnel. These tests are done to obtain additional information over and above routine lab tests for proper diagnosis of disease, establish a prognosis or select and supervise a therapeutic treatment. The test requires skilled personnel to perform the test and analyze the results due to usage of sophisticated chemicals and instruments and are not performed regularly owing to high cost. The market is expected to show significant growth during the forecast period. The growth may be attributed to the increasing prevalence of rare and complex diseases and rising awareness regarding the early diagnosis of the disease using special techniques. Technological advancements in esoteric testing will also augment the growth of the market during the given forecast period. However, high cost of the esoteric testing procedures coupled with stringent regulatory framework might restrain the growth of the market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Esoteric Assays market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Esoteric Assays market.

Major industry players profiled as part of the report are Miraca Group, Quest Diagnostics and Sonic Healthcare among others.

Segmentation

By Technology

Mass spectrometry

Flow cytometry

Real-Time PCR

Enzyme-linked immunosorbent assay (ELISA)

Radioimmunoassay (RIA)

Chemiluminescence

Others


By Application

Oncology

Neurology

Infectious Diseases

Genetic Diseases

Toxicology

Others


By End Users

Hospitals Laboratories

Independent & Reference Laboratories


By Geography

North America

United States

Canada

Others


South America

Brazil

Argentina

Others


Europe

United Kingdom

Germany

France

Others


Middle East and Africa

Saudi Arabia

UAE

Israel

Others


Asia Pacific

China

India

Australia

South Korea

Others

 

Key questions answered by the report

What will be the global Esoteric Assays market size from 2018 to 2023?

How are the major drivers and restraints affecting the global Esoteric Assays market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth


1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Global Esoteric Assays Market Forecast by Technology
5.1. Mass spectrometry
5.2. Flow cytometry 
5.3. Real-Time PCR
5.4. Enzyme-linked immunosorbent assay (ELISA)
5.5. Radioimmunoassay (RIA)
5.6. Chemiluminescence
5.7. Others
6. Global Esoteric Assays Market Forecast by Application
6.1. Oncology
6.2. Neurology
6.3. Infectious Diseases
6.4. Genetic Diseases
6.5. Toxicology
6.6. Others
7. Global Esoteric Assays Market Forecast by End User
7.1. Hospitals Laboratories
7.2. Independent & Reference Laboratories
8. Global Esoteric Assays Market Forecast by Geography 
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil 
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific 
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others 
9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company Profiles
10.1. Qualisys Diagnostics Inc. 
10.1.1. Overview 
10.1.2. Financials 
10.1.3. Product and Services 
10.1.4. Recent Developments
10.2. Quest Diagnostics Incorporated
10.2.1. Overview 
10.2.2. Financials 
10.2.3. Product and Services 
10.2.4. Recent Developments
10.3. Laboratory Corporation of America Holdings
10.3.1. Overview 
10.3.2. Financials 
10.3.3. Product and Services 
10.3.4. Recent Developments
10.4. Miraca Group
10.4.1. Overview 
10.4.2. Financials 
10.4.3. Product and Services 
10.4.4. Recent Developments
10.5. Sonic Healthcare Limited
10.5.1. Overview 
10.5.2. Financials 
10.5.3. Product and Services 
10.5.4. Recent Developments
10.6. Eurofins Scientific
10.6.1. Overview 
10.6.2. Financials 
10.6.3. Product and Services 
10.6.4. Recent Developments
10.7. ACM Global Laboratories
10.7.1. Overview 
10.7.2. Financials 
10.7.3. Product and Services 
10.7.4. Recent Developments
10.8. ChRi Labs
10.8.1. Overview 
10.8.2. Financials 
10.8.3. Product and Services 
10.8.4. Recent Developments
10.9. Clearbridge Health Limited
10.9.1. Overview 
10.9.2. Financials 
10.9.3. Product and Services 
10.9.4. Recent Developments
10.10. Q2 Solutions
10.10.1. Overview 
10.10.2. Financials 
10.10.3. Product and Services 
10.10.4. Recent Developments

Qualisys Diagnostics Inc.

Quest Diagnostics Incorporated

Laboratory Corporation of America Holdings

Miraca Group

Sonic Healthcare Limited

Eurofins Scientific

ACM Global Laboratories

ChRi Labs

Clearbridge Health Limited

Q2 Solutions